Member Info for Bobat123

Blue Star Capital plc

("Blue Star" or the "Company")

SatoshiPay Update

Blue Star Capital plc (AIM: BLU), the investing company with a focus on blockchain, esports and payments, notes the announcement by SatoshiPay Ltd ("SatoshiPay"), its investee company, that Vortex, a decentralised exchange platform incubated by SatoshiPay, designed to enhance global payments by bridging stablecoins with local fiat currencies, has achieved $1 million in transaction volumes since launching in Europe and Brazil, with $507,000 of the total achieved in May 2025.

The Vortex platform enables users to seamlessly swap stablecoins for local fiat currencies at significantly lower costs than current market rates. This presents a substantial opportunity in a rapidly growing market, with cross-border stablecoin payments valued at US$27 billion in 2023 and projected to reach US$137 billion by 2028. This growth highlights a US$14 billion volume in the on/off-ramp market opportunity over the next four years.

Vortex's business model is built around enabling easy to complete currency conversions and bank transfers with ultra-low costs and no hidden fees. Vortex achieves this with a stablecoin-optimised decentralized exchange together with local- currency on and offramp partners. By leveraging chain abstraction, Vortex offers a fluid user experience across different blockchain ecosystems. Vortex builds on top of Nabla technology and uses Pendulum infrastructure for providing its service to users of various blockchains such as Polygon, Base, BSC, Ethereum and Polkadot.

At present Vortex is available in Brazil and Europe and currently facilitates immediate conversions of USD Coin (USDC) and USDT (Tether), into EUR (SEPA) and Brazilian real (BRL), via PIX, Brazil's instant payment system created and managed by the Central Bank of Brazil.

Year high 14

Constant 100000 buys during the week

Speed ticket??. Hope we don't get one

Year high

52 Week High 6.25.

Yes all my buys. Daily buys coming in. 3p on the horizon by end of the week

Buys getting printed.

Hopefully can see this move up this week. Also lots of news to follow

Mms need shares to fill orders

Constant buys coming in

23-May-25 13:32:39 2.22 100,000 Buy* 1.75 2.30 2,220 O

23-May-25 13:20:33 2.22 100,000 Buy* 1.75 2.30 2,220 O

23-May-25 12:35:17 2.21 50,000 Buy* 1.75 2.30 1,105 O

23-May-25 12:13:45 2.20 150,000 Buy* 1.75 2.30 3,300 O

23-May-25 12:02:13 2.20 100,000 Buy* 1.75 2.30 2,200

Https://www.share-talk.com/rns-hotlist-with-zak-mir-ftse-100-ctai-bzt-ajax-bres-cass-ensi-mila-jd-svml-mks-he1-cury-revb-bsfa-gscu/.

BSF Enterprise (BSFA) a leading innovator in tissue-engineered materials is pleased to announce significant progress in its 100% owned subsidiary, Lab-Grown Leather Ltd, a pioneer in the development of sustainable, high-quality, lab-grown leather. LGL is applying its patented advanced tissue engineering platform (ATEP™) to create leather alternatives for high-value markets, including luxury goods, aerospace, and automotive.

Comment: The market clearly liked last month’s JV news on T-Rex, hence today’s update to re-stoke the fire.BSF Enterprise (BSFA) a leading innovator in tissue-engineered materials is pleased to announce significant progress in its 100% owned subsidiary, Lab-Grown Leather Ltd, a pioneer in the development of sustainable, high-quality, lab-grown leather. LGL is applying its patented advanced tissue engineering platform (ATEP™) to create leather alternatives for high-value markets, including luxury goods, aerospace, and automotive.

Comment: The market clearly liked last month’s JV news on T-Rex, hence today’s update to re-stoke the fire.

BSF Enterprise PLC

15p Warrants Amended

BSF Enterprise PLC (LSE:BSFA) (the "Company") a leading innovator in tissue-engineered materials is pleased to announce that it has agreed to amend the warrant instrument issued on 26 April 2022 ("Warrant Instrument") constituting warrants to subscribe for 12,270,217 ordinary shares of one penny each in the capital of the Company at 15p for a period of 3 years (the "Warrants").

The Warrant Instrument has been amended to reduce the exercise price for each of the Warrants from 15p to 7.5p and extend the exercise term by 2 years, to expire on 17 May 2027.

The amendment will not affect any other provisions of the Warrants or any other rights or obligations of the warrantholders.

Rns out l

Here it is

BSF Enterprise PLC ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has conditionally placed 4,725,000 new ordinary shares in the Company ("Placing Shares") raising £141,750 at 3p per share in a placing ("Placing") within the Company's remaining headroom for shares available under the Financial Conduct's Authority Rules.

Shard Capital is acting as sole broker to the Company.

In light of the significant news on T-Rex leather last Friday we had some small additional headroom for investment and this fundraise represents continuing support from the Company's largest shareholder to bolster the Company's strategic business and growth plans, with the possibility of significant value inflection points throughout 2025.

Completion of the Placing is conditional on, inter alia, the Placing Shares being admitted to listing on the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). Admission is expected before 15 May 2025.

Applications will be made to the FCA and to the London Stock Exchange for Admission in respect of all the Placing Shares proposed to be issued on completion of the Placing.

Shares with no RNs go up over 40-50% and with excellent news here no interest.

Lovely moved some profits into BSF. Gla

Placing done at 3p. Very undervalued

From last month RNs

BSF Enterprise PLC (BSF), a leading innovator in tissue-engineered materials, is pleased to announce that its wholly-owned subsidiary, Lab-Grown Leather Ltd (LGL) is transitioning its lab-grown leather technology from lab-scale to future products in a major step towards commercialization.

A frontrunner of these future products is Elemental X™ - the boldest realisation of what LGL's lab-grown leather can achieve. Developed using its proprietary Advanced Tissue Engineering Platform (ATEP™), it represents a new era of luxury and performance - where leather doesn't just echo tradition, it redefines what's possible.

In a pioneering venture, Lab-Grown Leather Ltd has partnered with VML (a group company of WPP PLC) and genomic engineering leader The Organoid Company to create the first-ever leather inspired by the DNA of an extinct species: Tyrannosaurus rex.

Many peeps have not even read the RNs. This should start to move

BSF Enterprise PLC

Lab-Grown Leather Ltd Progress

BSF Enterprise PLC (LSE:BSFA) a leading innovator in tissue-engineered materials is pleased to announce significant progress in its 100% owned subsidiary, Lab-Grown Leather Ltd ("LGL"), a pioneer in the development of sustainable, high-quality, lab-grown leather. LGL is applying its patented advanced tissue engineering platform (ATEP™) to create leather alternatives for high-value markets, including luxury goods, aerospace, and automotive.

Product Development Highlights

LGL is developing three core product lines:

● Elemental Leather™: Premium, high-end luxury leather, identical in feel, look, and smell to traditional leather. It is 100% lab-grown, free of scaffolds and additives.

● Elemental+™: High-performance, lightweight, and thin new-age leather.

● Elemental X™: Novel leather enabled by engineering biology, AI, and a proprietary cell expression system. This includes the groundbreaking T-Rex leather.

Elemental+™: New Ultra-Thin and Strong Leather

LGL has achieved a significant breakthrough with Elemental+™. Traditional animal leather loses integrity and strength when processed below 0.4mm. However, Elemental+™ can be produced at an astonishing thickness of just 0.04mm - a hundred times thinner than the thickest traditional leather-while maintaining comparable strength and durability. This has been achieved using vegetable-derived tanning components, making it more environmentally friendly. This innovation, and associated new patent filing, opens new possibilities for applications in sectors where weight is critical, such as sportswear, electric vehicles, and aerospace.

Dr Che Connon of Lab-Grown Leather Ltd. stated, "Elemental+™ is a testament to the power of our Advanced Tissue Engineering Platform and our commitment to pushing the boundaries of what biofabricated materials can achieve. We've engineered a new form of leather that retains the desirable properties of traditional leather while offering a level of thinness and strength previously unattainable. This opens up entirely new design and functional possibilities for industries where every gram counts."

Elemental X™: T-Rex Leather

LGL has also made substantial progress with Elemental X™, including the development of T-Rex leather. This world-first material, to be derived from synthetic T-Rex DNA, has garnered significant media attention. The leather will be grown in LGL's facilities in Newcastle upon Tyne, UK. Unlike other producers, LGL's finished leather contains no synthetic scaffolds or plastics. Elemental X leather can be made from unlimited species types (past or present). In collaboration with The Organoid Company and VML, a subsidiary of WPP plc, we will promote and scale the Lab-Grown T-Rex Leather product. Given its unique nature and limited initial availability, T-Rex leather is expected to be exclusive and priced at a substantial premium.

Media around